Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Lipid metabolite profiling identifies desmosterol metabolism as a new antiviral target for hepatitis C virus.

Rodgers MA, Villareal VA, Schaefer EA, Peng LF, Corey KE, Chung RT, Yang PL.

J Am Chem Soc. 2012 Apr 25;134(16):6896-9. doi: 10.1021/ja207391q. Epub 2012 Apr 11.

2.

Desmosterol Increases Lipid Bilayer Fluidity during Hepatitis C Virus Infection.

Costello DA, Villareal VA, Yang PL.

ACS Infect Dis. 2016 Nov 11;2(11):852-862. Epub 2016 Aug 25.

3.

Hepatitis C Virus Selectively Alters the Intracellular Localization of Desmosterol.

Villareal VA, Fu D, Costello DA, Xie XS, Yang PL.

ACS Chem Biol. 2016 Jul 15;11(7):1827-33. doi: 10.1021/acschembio.6b00324. Epub 2016 May 6.

4.

Lipids: a key for hepatitis C virus entry and a potential target for antiviral strategies.

Blaising J, Pécheur EI.

Biochimie. 2013 Jan;95(1):96-102. doi: 10.1016/j.biochi.2012.07.016. Epub 2012 Aug 1. Review.

PMID:
22884392
5.

Endocannabinoid CB1 antagonists inhibit hepatitis C virus production, providing a novel class of antiviral host-targeting agents.

Shahidi M, Tay ES, Read SA, Ramezani-Moghadam M, Chayama K, George J, Douglas MW.

J Gen Virol. 2014 Nov;95(Pt 11):2468-79. doi: 10.1099/vir.0.067231-0. Epub 2014 Jul 22.

PMID:
25053565
6.

2-octynoic acid inhibits hepatitis C virus infection through activation of AMP-activated protein kinase.

Yang D, Xue B, Wang X, Yu X, Liu N, Gao Y, Liu C, Zhu H.

PLoS One. 2013 May 31;8(5):e64932. doi: 10.1371/journal.pone.0064932. Print 2013.

7.

Targeting host lipid synthesis and metabolism to inhibit dengue and hepatitis C viruses.

Villareal VA, Rodgers MA, Costello DA, Yang PL.

Antiviral Res. 2015 Dec;124:110-21. doi: 10.1016/j.antiviral.2015.10.013. Epub 2015 Oct 23. Review.

8.

Modulation of host metabolism as a target of new antivirals.

Ikeda M, Kato N.

Adv Drug Deliv Rev. 2007 Oct 10;59(12):1277-89. Epub 2007 Aug 11. Review.

PMID:
17897752
9.

Evaluation systems for anti-HCV drugs.

Moriishi K, Matsuura Y.

Adv Drug Deliv Rev. 2007 Oct 10;59(12):1213-21. Epub 2007 Aug 9. Review.

PMID:
17720275
10.

Interferon-inducible cholesterol-25-hydroxylase inhibits hepatitis C virus replication via distinct mechanisms.

Chen Y, Wang S, Yi Z, Tian H, Aliyari R, Li Y, Chen G, Liu P, Zhong J, Chen X, Du P, Su L, Qin FX, Deng H, Cheng G.

Sci Rep. 2014 Dec 3;4:7242. doi: 10.1038/srep07242.

11.

Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis C Virus infection in vitro and in vivo.

Pan Q, de Ruiter PE, Metselaar HJ, Kwekkeboom J, de Jonge J, Tilanus HW, Janssen HL, van der Laan LJ.

Hepatology. 2012 Jun;55(6):1673-83. doi: 10.1002/hep.25562. Epub 2012 Apr 18.

PMID:
22213147
12.

[Effects of telaprevir (TVR) on cholesterol metabolism].

Nakamuta M, Kohjima M.

Nihon Rinsho. 2015 Dec;73 Suppl 9:199-203. Japanese. No abstract available.

PMID:
26845930
13.

Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection.

Bocchetta S, Maillard P, Yamamoto M, Gondeau C, Douam F, Lebreton S, Lagaye S, Pol S, Helle F, Plengpanich W, Guérin M, Bourgine M, Michel ML, Lavillette D, Roingeard P, le Goff W, Budkowska A.

PLoS One. 2014 Mar 19;9(3):e92140. doi: 10.1371/journal.pone.0092140. eCollection 2014.

14.
16.

Soraphen A: A broad-spectrum antiviral natural product with potent anti-hepatitis C virus activity.

Koutsoudakis G, Romero-Brey I, Berger C, Pérez-Vilaró G, Monteiro Perin P, Vondran FW, Kalesse M, Harmrolfs K, Müller R, Martinez JP, Pietschmann T, Bartenschlager R, Brönstrup M, Meyerhans A, Díez J.

J Hepatol. 2015 Oct;63(4):813-21. doi: 10.1016/j.jhep.2015.06.002. Epub 2015 Jun 10.

PMID:
26070407
17.

NS5A--from obscurity to new target for HCV therapy.

Schmitz U, Tan SL.

Recent Pat Antiinfect Drug Discov. 2008 Jun;3(2):77-92. Review.

PMID:
18673121
18.
19.

Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics.

Guedj J, Neumann AU.

J Theor Biol. 2010 Dec 7;267(3):330-40. doi: 10.1016/j.jtbi.2010.08.036. Epub 2010 Sep 8.

PMID:
20831874
20.

Chemical genetics-based discovery of indole derivatives as HCV NS5B polymerase inhibitors.

Jin G, Lee S, Choi M, Son S, Kim GW, Oh JW, Lee C, Lee K.

Eur J Med Chem. 2014 Mar 21;75:413-25. doi: 10.1016/j.ejmech.2014.01.062. Epub 2014 Jan 31.

PMID:
24561671

Supplemental Content

Support Center